Osteochondroses
Osteochondrosis is disordered behavior of growing cartilage under load. This may include compressive or tensile loads. Most common age to present is 7 to 12 years.
4.1.1 Classification
Spine: Scheuermann kyphosis.
Upper extremity:
Panner disease (capitellum).
Madelung deformity (distal radial physis).
Lower extremity:
Perthes disease.
Osgood–Schlatter disease (tibial tubercle).
Blount disease (medial tibial physis).
Kohler disease (tarsal navicular).
Freiberg disease (second metatarsal head).
Sever disease (calcaneal apophysis).
4.1.2 Treatment
Cartilage heals and remodels with time.
Minimize load.
Bracing may help (Blount, Scheuermann).
Reconstruct if deformity develops (Perthes, Scheuermann, Blount, Madelung).
Bibliography
Crawford H. Localized disorders of bone. In: Flynn J, Weinstein SL, eds. Lovell and Winter’s Pediatric Orthopaedics. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2014:278–319
Maier GS, Lazovic D, Maus U, Roth KE, Horas K, Seeger JB. Vitamin D deficiency: the missing etiological factor in the development of juvenile osteochondrosis dissecans? J Pediatr Orthop. 2019 Jan;39(1):51-54
4.2 Musculoskeletal Tumors
Most pediatric skeletal tumors are benign. The most common primary malignancies include osteosarcoma, Ewing sarcoma, and rhabdomyosarcoma. Secondary pediatric skeletal involvement may occur with leukemia and neuroblastoma and peripheral neuroectodermal tumor.
4.2.1 Symptoms
Symptoms indicating possible malignancy include night pain that is not activity related, rapid increase in pain, increasing fatigue, or bruising.
4.2.2 Laboratory Studies
Erythrocyte sedimentation rate: mildly elevated for most malignant tumors.
Complete blood cell count: abnormal in leukemia and lymphoma.
4.2.3 Imaging
Plain films: Location, morphology, and host reaction are the most diagnostic features. Locations of most common benign and malignant tumors are shown in ▶ Fig. 4.1.
Radionuclide scans: Very sensitive for malignant bone and soft-tissue tumors; may be negative in eosinophilic granuloma.
CT: Best when bony changes need to be better defined.
MRI: Does not show bony detail well but does show soft tissue and intramedullary detail well.
Fig. 4.1 Sites of musculoskeletal tumors in skeletally immature and mature children. See tables below for explanation of abbreviations.
4.2.4 Tumor Types
Benign.
Eosinophilic granuloma: Reticuloendothelial lesion usually centrally located in one or several bones; poorly or well circumscribed. Usually waxes and wanes spontaneously.
Osteoid osteoma: Painful nidus surrounded by sclerosis; usually found in patients aged 6 to 25 years.
Osteochondroma (osteocartilaginous exostosis), metaphyseal, solitary, or multiple; growth ceases at maturity.
Chondromyxoid fibroma: Eccentric local lesion, usually in lower extremity progressively enlarging. Patients aged 10 to 25 years.
Chondroblastoma epiphyseal tumor of adolescence; lucent with foci of internal calcification.
Unicameral bone cyst: Central lucent metaphyseal lesion usually of proximal humerus or femur; expands and thins cortex; resolves at maturity.
Nonossifying fibroma: Eccentric intracortical deficit in metaphysis; resolves by maturity.
Adamantinoma (Adam): Sclerotic anterior cortical deficit, usually of tibia.
Enchondroma (ench) central lucent defect with internal calcification.
Giant cell tumor: Lucent epimetaphyseal tumor just after maturity.
Aneurysmal bone cyst: Expansile metaphyseal lesion of late adolescence that destroys cortex but leaves thin shell.
Malignant:
Fibrosarcoma.
Osteosarcoma: Most common primarily malignant bone tumor, metaphyseal; located in fastest growing regions.
Chondrosarcoma: Central or peripheral, expansile tumor of young adults.
Ewing sarcoma: Small cell tumor of diaphysis; patients aged 5 to 15 years; usually lasts with extensive periosteal reaction.
4.2.5 Tumors Common to Specific Locations in Children
Long bones (▶ Fig. 4.1).
Spine:
Posterior elements:
Aneurysmal bone cyst.
Osteoid osteoma.
Osteoblastoma.
Vertebral body:
Histiocytosis.
Hemangioma.
Osteosarcoma.
Ewing sarcoma.
Chordoma.
Ribs:
Fibrous dysplasia.
Ewing sarcoma.
Chondrosarcoma.
Metastasis.
Pelvis:
Ewing sarcoma.
Fibrous dysplasia.
Aneurysmal bone cyst.
Osteoblastoma.
Eosinophilic granuloma.
Leukemia.
Osteosarcoma.
Scapula:
Ewing sarcoma.
Osteoblastoma.
Aneurysmal bone cyst.
4.2.6 Staging
Malignant tumors (▶ Table 4.1).
Benign tumors:
Latent.
Active.
Aggressive; may expand into soft tissues or metastasize (▶ Table 4.2).
Table 4.1 Staging of malignant tumors
Surgical stage
Surgical grade (G)
Site (T)
Metastases (M)
IA
Low (G1)
Intracompartmental (T1)
M0B
Low (G1)
Extracompartmental (T2)
M0
IIA
High (G2)
Intracompartmental (T1)
M0
High (G2)
Extracompartmental (T2)
M0
III
Any
Any T
Source: Data from Enneking WJ. Musculoskeletal Tumor Surgery. New York, NY: Churchill Livingstone; 1983.
Table 4.2 Common bone tumors
Type of tumor
Abbreviation
Name
Benign
EG
Eosinophilic granuloma
OO/OB
Osteoid osteoma/osteoblastoma
OC
Osteochondroma
CMF
Chondromyxofibroma
CB
Chondroblastoma
UBC
Unicameral bone cyst
NOF/FCD
Nonossifying fibroma/fibrous cortical defect
Adam
Adamantinoma
Ench
Enchondroma
GCT
Giant cell tumor
ABC
Aneurysmal bone cyst
Malignant
FS
Fibrosarcoma
OS
Osteosarcoma
CS
Chondrosarcoma
MFH
Malignant fibrous histiocytoma
POS
Parosteal osteosarcoma
Met
Metastasis
SS
Synovial sarcoma
RMS
Rhabdomyosarcoma
4.3 Musculoskeletal Problems in Hemophilia
Hemophilia A (factor VIII) and B (factor IX deficiency) are the two most common bleeding disorders, followed by von Willebrand disease. Factor level below 5% of normal level indicates risk of serious bleeding. These conditions should be jointly managed by hematology and orthopaedic specialists (▶ Table 4.3).
Factor | Rise after one unit/kg dose (%) | Approximate half-life (h) |
VIII | 2 | 12 |
IX | 1 | 24 |
4.3.1 Treatment of Acute Hemarthropathy
Factor replacement, 50% every 48 hours × 6 days.
Aspiration.
Immobilization.
Rehabilitation.
4.3.2 Treatment of Subacute Hemarthropathy
Factor replacement, 30% × 2 to 6 weeks.
Strengthen and increase range of motion.
Consider synovectomy if not resolved.
4.3.3 Control of Bleeding after Fracture
Factor replacement, 50% × 1 to 2 days.
Factor replacement, 30% × 1 week.
4.3.4 Imaging (Arnold Classification)
Soft-tissue swelling.
Osteopenia, epiphyseal overgrowth.
Subchondral cysts; wide or square contours.
Irregular joint space.
Absent joint space.